HAIA Stock Forecast 2025-2026
Distance to HAIA Price Targets
HAIA Price Momentum
10 Quality Stocks Worth Considering Now
Researching Healthcare AI (HAIA) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on HAIA and similar high-potential opportunities.
Latest HAIA Stock Price Targets & Analyst Predictions
HAIA has shown a year-to-date change of 3.2% and a 1-year change of 7.3%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for HAIA. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
HAIA Analyst Ratings
HAIA Price Target Range
Latest HAIA Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for HAIA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Healthcare AI Acquisition Corp. (HAIA) Competitors
The following stocks are similar to Healthcare AI based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Healthcare AI Acquisition Corp. (HAIA) Financial Data
Healthcare AI Acquisition Corp. has a market capitalization of $62.88M with a P/E ratio of 1,086.0x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of 0.0% and return on equity of +1.7%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Healthcare AI Acquisition Corp. (HAIA) Business Model
About Healthcare AI Acquisition Corp.
Specializes in mergers and acquisitions.
The company aims to generate revenue by executing a merger, share exchange, or acquisition with one or more businesses. By targeting promising entities, it seeks to create value for its shareholders through strategic partnerships and integrations.
Incorporated in 2021 and based in Dover, Delaware, the company operates as a subsidiary of Atticus Ale, LLC, which may provide additional support and resources during the acquisition process.
Healthcare AI Acquisition Corp. (HAIA) Latest News & Analysis
Leading Group Limited and Healthcare AI Acquisition Corp. have entered a definitive agreement for a merger, resulting in Leading as the surviving entity, set to list on Nasdaq post-transaction.
The merger between LEADING and HAIA could enhance market presence in digital insurance in China, potentially driving growth and attracting investor interest in the newly listed entity.
Healthcare AI Acquisition Corp. (NASDAQ:HAIA) received a Nasdaq notification for failing to file its Q1 2024 report on time. It has 60 days to submit a compliance plan.
Healthcare AI Acquisition Corp.'s failure to file its quarterly report raises compliance risks, potentially affecting stock performance and investor confidence. Timely recovery plans are crucial for stability.
Healthcare AI Acquisition Corp. (NASDAQ:HAIA) extended its business combination deadline by one month to August 14, 2023, with a $50,000 deposit from its sponsor and a $100,000 promissory note issued.
The extension indicates the SPAC's commitment to finding a suitable acquisition target, which can affect stock performance and investor confidence in the deal's potential value.
Frequently Asked Questions About HAIA Stock
What is Healthcare AI Acquisition Corp.'s (HAIA) stock forecast for 2025?
Analyst forecasts for Healthcare AI Acquisition Corp. (HAIA) are not currently available. The stock is trading at $11.80.
Is HAIA stock a good investment in 2025?
Analyst ratings for HAIA are not currently available. The stock is currently trading at $11.80. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for HAIA stock?
Price predictions from Wall Street analysts for HAIA are not currently available. The stock is trading at $11.80.
What is Healthcare AI Acquisition Corp.'s business model?
The company aims to generate revenue by executing a merger, share exchange, or acquisition with one or more businesses. By targeting promising entities, it seeks to create value for its shareholders through strategic partnerships and integrations.
What is the highest forecasted price for HAIA Healthcare AI Acquisition Corp.?
Price targets from Wall Street analysts for HAIA are not currently available. The stock is trading at $11.80.
What is the lowest forecasted price for HAIA Healthcare AI Acquisition Corp.?
Price targets from Wall Street analysts for HAIA are not currently available. The stock is trading at $11.80.
What is the overall HAIA consensus from analysts for Healthcare AI Acquisition Corp.?
Analyst ratings for HAIA are not currently available. The stock is trading at $11.80.
How accurate are HAIA stock price projections?
Stock price projections, including those for Healthcare AI Acquisition Corp., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.